Looking for markers that predict bowel disease course and treatment response
Collects biopsies and samples from adults with Crohn's or ulcerative colitis.
Key facts
- Who runs it
- Central Hospital, Nancy, France
- Where
- Vandœuvre-lès-Nancy, FranceSee the site
- Trial code
- Registry title
- IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 10 Dec 2019
- Expected to end
- 10 Dec 2034
- Type of study
- Interventional
- Treatments tested
- endoscopic biopsy
- samples of the oral cavity
- Samples of the resected specimen
- Record updated
- 7 February 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Crohn's disease or ulcerative colitis, to find markers that show how the disease develops and how people respond to biotherapies.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Established diagnosis of Crohn's disease (CD) or ulcerative colitis (UC), confirmed by clinical, biological, radiological, endoscopic or histologic criteria.
Main reasons for not taking part
- Undetermined colitis
- Crohn's disease diagnosis not established
- Women of childbearing age without a method of contraception
- Pregnant or breastfeeding women
- Persons under legal protection or unable to consent
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age>=18 years
- Patients with an established diagnosis of CD or UC (clinical, biological, radiological, endoscopic or histologic criteria)
- Patients >=45 kg
- Affiliated member of the Social Security system
Who cannot take part
- Women of childbearing age without a method of contraception
- Pregnant women, breastfeeding women; -- Age < 18 years
- Persons under the age of 18 years who are deprived of their liberty by decision of a judicial or administrative authority (articles L. 3212-1 and L. 3213-1)
- Patients with an undetermined colitis
- Patients with a non established diagnosis of CD
- Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code
- Persons under legal protection
- Person who does not have the capacity to consent
Where in France
- CHRU NancyVandœuvre-lès-Nancy, FranceContact: Marine BECKTaking people
About the trial
What the trial wants to find out
Interventional study of a group of patients with an inflammatory bowel disease (IBD; Crohn's disease (CD) or ulcerative colitis (UC)) to identify predictive and prognostic biomarkers of natural history and response to biotherapies.
The group in the trial
- IBD patientsOther group
All patients with an established Crohn's disease or ulcerative colitis
Treatment: endoscopic biopsy, samples of the oral cavity, and Samples of the resected specimen
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS OF NATURAL HISTORY AND RESPONSE TO BIOTHERAPIES IN INFLAMMATORY BOWEL DISEASE : i-BANK
- Plain-language title
- Looking for markers that predict bowel disease course and treatment responseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 7 February 2024